Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0P0ZB
|
|||
| Former ID |
DIB019847
|
|||
| Drug Name |
F3
|
|||
| Synonyms |
1-Chloro-1,2,2-trifluorocyclobutane; 661-71-2; Cyclobutane, 1-chloro-1,2,2-trifluoro-; 1-Ctfcb; AC1Q4KXO; AC1L2WN1; GTPL2400; SCHEMBL3123282; CTK5C3598; MolPort-001-773-111; ZX-AP007208; 7606AE; PC2028; 7607AE; FCH917920; SBB086362; MFCD00042139; AKOS006230600; Cyclobutane,1-chloro-1,2,2-trifluoro-; TR-022419; FT-0607576; C-47497; I14-28177
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL
|
||
| Formula |
C4H4ClF3
|
|||
| Canonical SMILES |
C1CC(C1(F)F)(F)Cl
|
|||
| InChI |
1S/C4H4ClF3/c5-3(6)1-2-4(3,7)8/h1-2H2
|
|||
| InChIKey |
ZZQYDYODFHABLC-UHFFFAOYSA-N
|
|||
| CAS Number |
CAS 661-71-2
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
3159885, 5604971, 8200195, 10532046, 15264959, 29328596, 43134617, 57332785, 74793006, 88816095, 95691051, 103099091, 104371818, 117506238, 125373148, 128715433, 129978166, 131498068, 132513227, 134380831, 135034035, 135579092, 135650249, 143455208, 160970324, 162891915, 164792735, 184574960, 229168479, 241116693, 252326469, 252502944, 252502951
|
|||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Inward rectifier potassium channel Kir3.2 (KCNJ6) | Target Info | Inhibitor (gating inhibitor) | [2] |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 2400). | |||
| REF 2 | Differential effects of general anesthetics on G protein-coupled inwardly rectifying and other potassium channels. Anesthesiology. 2001 Jul;95(1):144-53. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.